healthprotocol.wiki

Protocols Evidence Outcomes

therapy-chemotherapy-amivantamab-pemetrexed-carboplatin-first-cycle

Outcomes

01
biomarker-c-reactive-protein-serum-peak-milligrams-per-deciliter-measured
1 evidence row
- cui_2025_n1_cytokine-release-syndrome-and-rapid-tumor-response-in-a-patient-treated-with-amivantamab-and-chemotherapy
02
biomarker-interleukin-6-serum-peak-picograms-per-milliliter-measured
1 evidence row
- cui_2025_n1_cytokine-release-syndrome-and-rapid-tumor-response-in-a-patient-treated-with-amivantamab-and-chemotherapy
03
biomarker-lymphocyte-count-cells-per-microliter-measured
1 evidence row
- cui_2025_n1_cytokine-release-syndrome-and-rapid-tumor-response-in-a-patient-treated-with-amivantamab-and-chemotherapy
04
immune-cytokine-release-syndrome-grade-measured
1 evidence row
- cui_2025_n1_cytokine-release-syndrome-and-rapid-tumor-response-in-a-patient-treated-with-amivantamab-and-chemotherapy
05
oncology-tumor-volume-reduction-percent-ct-measured
1 evidence row
- cui_2025_n1_cytokine-release-syndrome-and-rapid-tumor-response-in-a-patient-treated-with-amivantamab-and-chemotherapy

Evidence

1rows

On this page

Permalink

/protocols/therapy-chemotherapy-amivantamab-pemetrexed-carboplatin-first-cycle

healthprotocol.wiki

A community-driven, evidence-based health registry. Built for transparency.